These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8910977)

  • 41. Toxicity testing.
    Bailey GP
    Reprod Toxicol; 2011 Sep; 32(2):149. PubMed ID: 21683782
    [No Abstract]   [Full Text] [Related]  

  • 42. Proceedings of the Consensus Workshop on In Vitro Teratogenesis Testing. August 2-5, 1981 Arkadelphia, Arkansas.
    Teratog Carcinog Mutagen; 1982; 2(3-4):221-374. PubMed ID: 6130621
    [No Abstract]   [Full Text] [Related]  

  • 43. When scientists become policy makers: shaping hazard identification under Proposition 65.
    Pease W
    Reprod Toxicol; 1991; 5(3):169-73; discussion 175-8. PubMed ID: 1807551
    [No Abstract]   [Full Text] [Related]  

  • 44. Prospects for the development of validated screening tests that measure developmental toxicity potential: view of one skeptic.
    Mirkes PE
    Teratology; 1996 Jun; 53(6):334-8. PubMed ID: 8910978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Chernoff/Kavlock test for developmental toxicity. Proceedings of the Workshop on the Chernoff/Kavlock Short Term In Vivo Developmental Toxicity Test. Cincinnati, Ohio, May 20 and 21, 1986.
    Teratog Carcinog Mutagen; 1987; 7(1):1-127. PubMed ID: 2884736
    [No Abstract]   [Full Text] [Related]  

  • 46. Background for two perspectives on the status and prospects of in vitro and short-term prescreening tests for developmental toxicity hazard potential.
    Welsch F
    Teratology; 1996 Jun; 53(6):332-3. PubMed ID: 8910977
    [No Abstract]   [Full Text] [Related]  

  • 47. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of alternative methods for developmental toxicity testing.
    Piersma AH
    Toxicol Lett; 2004 Apr; 149(1-3):147-53. PubMed ID: 15093260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NSAIDs and developmental toxicity.
    Tassinari MS; Cook JC; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):3-4. PubMed ID: 12852479
    [No Abstract]   [Full Text] [Related]  

  • 50. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atenolol developmental toxicity: animal-to-human comparisons.
    Tabacova S; Kimmel CA; Wall K; Hansen D
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):181-92. PubMed ID: 12797460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NTP-CERHR expert panel report on the reproductive and developmental toxicity of methanol.
    Shelby M; Portier C; Goldman L; Moore J; Iannucci A; Jahnke G; Donkin S;
    Reprod Toxicol; 2004 May; 18(3):303-90. PubMed ID: 15082073
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.